Company Of The Day: Johnson & Johnson

JNJ: Johnson & Johnson logo
Johnson & Johnson


Johnson & Johnson (NYSE:JNJ) posted a stronger than expected Q3 2021 profit, with adjusted EPS rising by about 18% year-over-year to about $2.60. While revenues grew 11% to $23.34 billion, they fell short of estimates.


Relevant Articles
  1. Should You Buy Johnson & Johnson Stock At $177?
  2. Here’s Why Centene Stock Is A Better Bet Compared To This Pharmaceuticals Bellwether
  3. This Semiconductor Chip Company Is Likely To Offer Better Returns Over Johnson & Johnson Stock
  4. Does Johnson & Johnson Stock Have More Upside?
  5. Company Of The Day: Johnson & Johnson
  6. Here’s Why Humira Maker Is A Better Bet Compared To Johnson & Johnson Stock

The results were driven by a strong performance of the pharmaceuticals business, ongoing recovery in medical devices, and growth in the consumer healthcare space.

So What?

J&J stock rose by about 2% in Tuesday’s trading.

See Our Complete Analysis For Johnson & Johnson

What if you’re looking for a more balanced portfolio instead? Here’s a high-quality portfolio that’s beaten the market consistently since 2016.

Invest with Trefis Market Beating Portfolios

 See all Trefis Price Estimates